Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors
Phase 1
Not yet recruiting
- Conditions
- Advanced or Metastatic Solid Tumors
- Interventions
- Drug: MHB088C for Injection
- First Posted Date
- 2022-12-15
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Minghui Pharmaceutical Pty Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT05652855
- Locations
- 🇦🇺
Pindara Private Hospital, Gold Coast, Queensland, Australia
🇦🇺Southern Oncology Clinical Research Unit, Adelaide, South Australia, Australia
🇦🇺Cabrini Health, Melbourne, Victoria, Australia
Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Minghui Pharmaceutical Pty Ltd
- Target Recruit Count
- 400
- Registration Number
- NCT05642949
- Locations
- 🇦🇺
Pindara Private Hospital, Gold Coast, Queensland, Australia
🇦🇺Southern Oncology Clinical Research Unit, Adelaide, South Australia, Australia
🇦🇺Cabrini Health, Melbourne, Victoria, Australia
MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis
Phase 1
- Conditions
- Atopic DermatitisRheumatoid Arthritis
- Interventions
- Drug: MH004 Ia(1%)Drug: MH004 Ia(3%)Drug: MH004 Ib-1(1%)Drug: MH004 Ib-2(0.3%)Drug: MH004 Ia(0.3%)Drug: MH004 Ib-1(0.1%)Drug: MH004 Ib-2(1%)Drug: MH004 Ib-2(3%)Drug: MH004 Ia(0.1%)Drug: MH004 Ib-1(0.3%)
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Minghui Pharmaceutical Pty Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT04815148
News
No news found